{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:32:32Z","timestamp":1794274352921,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Myasthenia gravis (MG), a chronic neuromuscular disorder, can adversely affect patients\u2019 health-related quality of life (HRQoL), especially in women. The study aimed to evaluate the difference in HRQoL of women and men MG patients and explore the factors that mediate the relationship between gender and HRQoL.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional study was conducted among 1815 patients with MG in China. The revised 15-item MG quality of life scale (MG-QOL15r) was used to access patients\u2019 HRQoL in overall, physical, social and emotional domains. Socio-demographic information, diagnosis and treatment history, comorbidities, social support, active lifestyle and the MG activities of daily living scale (MG-ADL) were recorded and compared between women and men using the Student\u2019s t-test and Pearson\u2019s Chi-square test. Multivariable regression analyses were conducted to identify independent contributors to HRQoL, especially those affecting different gender.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>On average, female patients with MG reported a lower MG-QOL15r score than the males (44.49\u2009\u00b1\u200929.10 vs 49.32\u2009\u00b1\u200929.18). The association between gender and patients\u2019 HRQoL interacted with the number of comorbidities across the overall, physical and social domains of patients. As the number of comorbidities increased, the scores of HRQoL decreased and it was faster among females than the males (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Moreover, unemployment, exacerbation of the disease, and active lifestyle contributed to the patients\u2019 HRQoL across all domains. Unemployment (\u03b2\u2009=\u2009\u2212\u20094.99 [95%CI, \u2212\u20097.80 to \u2212\u20092.18], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and exacerbations (\u03b2\u2009=\u2009\u2212\u20098.49 [95%CI, \u2212\u200911.43 to \u2212\u20095.54], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were correlated with poorer HRQoL; while an active lifestyle had a positive impact on HRQoL (\u03b2\u2009=\u20090.28 [95%CI, 0.16 to 0.40], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The results indicate that the HRQoL of women MG patients was lower than that of men. The relationship between gender and HRQoL is modulated by the number of comorbidities. Thus, to improve the HRQoL of women MG patients, symptomatic treatments might not be enough, their comorbid conditions should be considered as well. Additionally, employment status, MG exacerbations, and an active lifestyle have been found as determining factors of the patients\u2019 HRQoL, which suggests future interventions should cope with these factors to improve their quality of life.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12955-020-01549-z","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:03:43Z","timestamp":1599134623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Gender differences in quality of life among patients with myasthenia gravis in China"],"prefix":"10.1186","volume":"18","author":[{"given":"Dong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Ka-chun","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-4777","authenticated-orcid":false,"given":"Siyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"1549_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375:2570\u201381. https:\/\/doi.org\/10.1056\/NEJMra1602678.","journal-title":"N Engl J Med"},{"key":"1549_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46. https:\/\/doi.org\/10.1186\/1471-2377-10-46.","journal-title":"BMC Neurol"},{"key":"1549_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10072-019-04146-1","volume":"41","author":"W Fang","year":"2020","unstructured":"Fang W, Li Y, Mo R, Wang J, Qiu L, Ou C, et al. Hospital and healthcare insurance system record\u2013based epidemiological study of myasthenia gravis in southern and northern China. Neurol Sci. 2020;41:1211\u201323. https:\/\/doi.org\/10.1007\/s10072-019-04146-1.","journal-title":"Neurol Sci"},{"key":"1549_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34:645\u20139. https:\/\/doi.org\/10.1007\/s40273-016-0389-9.","journal-title":"Pharmacoeconomics."},{"key":"1549_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","volume":"33","author":"IZ Basta","year":"2012","unstructured":"Basta IZ, Pekmezovi\u0107 TD, Peri\u0107 SZ, Kisi\u0107-Tepav\u010devi\u0107 DB, Rako\u010devi\u0107-Stojanovi\u0107 VM, Stevi\u0107 ZD, Lavrni\u0107 DV. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci. 2012;33:1375\u201381. https:\/\/doi.org\/10.1007\/s10072-012-1170-2.","journal-title":"Neurol Sci"},{"key":"1549_CR6","first-page":"1167","volume":"93","author":"K Kulkantrakorn","year":"2010","unstructured":"Kulkantrakorn K, Jarungkiatkul W. Quality of life of myasthenia gravis patients. J Med Assoc Thail. 2010;93:1167\u201371.","journal-title":"J Med Assoc Thail"},{"key":"1549_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, Tonali P. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci. 2001;22:363\u20139. https:\/\/doi.org\/10.1007\/s100720100066.","journal-title":"Neurol Sci"},{"key":"1549_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/00207454.2015.1038712","volume":"126","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhang M, Guo J, Ma S, Fan L, Wang X, et al. Quality of life in 188 patients with myasthenia gravis in China. Int J Neurosci. 2016;126:455\u201362. https:\/\/doi.org\/10.3109\/00207454.2015.1038712.","journal-title":"Int J Neurosci"},{"key":"1549_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mus.21016","volume":"38","author":"LL Mullins","year":"2008","unstructured":"Mullins LL, Carpentier MY, Paul RH, Sanders DB. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve. 2008;38:947\u201356. https:\/\/doi.org\/10.1002\/mus.21016.","journal-title":"Muscle Nerve"},{"key":"1549_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve. 2008;38:957\u201363. https:\/\/doi.org\/10.1002\/mus.21053.","journal-title":"Muscle Nerve"},{"key":"1549_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/mus.25198","volume":"54","author":"TM Burns","year":"2016","unstructured":"Burns TM, Sadjadi R, Utsugisawa K, Gwathmey KG, Joshi A, Jones S, et al. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r. Muscle Nerve. 2016;54:1015\u201322. https:\/\/doi.org\/10.1002\/mus.25198.","journal-title":"Muscle Nerve"},{"key":"1549_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6061\/clinics\/2016(07)03","volume":"71","author":"AM Mour\u00e3o","year":"2016","unstructured":"Mour\u00e3o AM, Gomez RS, Barbosa LSM, Freitas DS, Comini-Frota ER, Kummer A, et al. Determinants of quality of life in Brazilian patients with myasthenia gravis. Clinics (Sao Paulo). 2016;71:370\u20134. https:\/\/doi.org\/10.6061\/clinics\/2016(07)03.","journal-title":"Clinics (Sao Paulo)"},{"key":"1549_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/mus.24213","volume":"50","author":"K Utsugisawa","year":"2014","unstructured":"Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Murai H, Imai T, et al. Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve. 2014;50:493\u2013500. https:\/\/doi.org\/10.1002\/mus.24213.","journal-title":"Muscle Nerve"},{"key":"1549_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223\u201343. https:\/\/doi.org\/10.1006\/clin.1997.4412.","journal-title":"Clin Immunol Immunopathol"},{"key":"1549_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1600-0404.1992.tb05050.x","volume":"86","author":"YL Yu","year":"1992","unstructured":"Yu YL, Hawkins BR, Ip MSM, Wong V, Woo E. Myasthenia gravis in Hong Kong Chinese. Acta Neurol Scand. 1992;86:113\u20139. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb05050.x.","journal-title":"Acta Neurol Scand"},{"key":"1549_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141\u20139. https:\/\/doi.org\/10.1002\/mus.20950.","journal-title":"Muscle Nerve"},{"key":"1549_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, P\u00f6hlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes. 2010;8:129. https:\/\/doi.org\/10.1186\/1477-7525-8-129.","journal-title":"Health Qual Life Outcomes"},{"key":"1549_CR18","doi-asserted-by":"publisher","unstructured":"Lee I, Kaminski HJ, Xin H, Cutter G. Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry. Muscle Nerve. 2018. https:\/\/doi.org\/10.1002\/mus.26104.","DOI":"10.1002\/mus.26104"},{"key":"1549_CR19","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000507","volume":"5","author":"I Lee","year":"2018","unstructured":"Lee I, Kaminski HJ, McPherson T, Feese M, Cutter G. Gender differences in prednisone adverse effects. Neurol Neuroimmunol Neuroinflamm. 2018;5:e507. https:\/\/doi.org\/10.1212\/NXI.0000000000000507.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1549_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"841","author":"RJ Barohn","year":"1998","unstructured":"Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci. 1998;841:769\u201372. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb11015.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1549_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-b","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705\u201314. https:\/\/doi.org\/10.1016\/0277-9536(91)90150-b.","journal-title":"Soc Sci Med"},{"key":"1549_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2753\/CSA2162-0555450104","volume":"45","author":"Y Bian","year":"2012","unstructured":"Bian Y, Li L. The Chinese general social survey (2003-8). Chin Sociological Rev. 2012;45:70\u201397. https:\/\/doi.org\/10.2753\/CSA2162-0555450104.","journal-title":"Chin Sociological Rev"},{"key":"1549_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/nur.20008","volume":"27","author":"DSF Yu","year":"2004","unstructured":"Yu DSF, Lee DTF, Woo J. Psychometric testing of the Chinese version of the medical outcomes study social support survey (MOS-SSS-C). Res Nurs Health. 2004;27:135\u201343.","journal-title":"Res Nurs Health"},{"key":"1549_CR24","first-page":"458","volume":"5","author":"P Liu","year":"2017","unstructured":"Liu P, Li T. Application of myasthenia gravis-quality of Life-15 in Chinese patients with myasthenia gravis. Stroke Neurological Dis. 2017;5:458\u201360.","journal-title":"Stroke Neurological Dis"},{"key":"1549_CR25","volume-title":"Evaluation of the scales measuring severity of myasthenia gravis","author":"X Gao","year":"2013","unstructured":"Gao X. Evaluation of the scales measuring severity of myasthenia gravis. Shandong: Qingdao University; 2013."},{"key":"1549_CR26","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1212\/WNL.0000000000003339","volume":"87","author":"MI Boldingh","year":"2016","unstructured":"Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekj\u00e6r H, Verschuuren JJGM, Tallaksen CME. Increased risk for clinical onset of myasthenia gravis during the postpartum period. Neurology. 2016;87:2139\u201345. https:\/\/doi.org\/10.1212\/WNL.0000000000003339.","journal-title":"Neurology."},{"key":"1549_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0022-510X(98)00031-8","volume":"156","author":"RR Leker","year":"1998","unstructured":"Leker RR, Karni A, Abramsky O. Exacerbation of myasthenia gravis during the menstrual period. J Neurol Sci. 1998;156:107\u201311. https:\/\/doi.org\/10.1016\/S0022-510X(98)00031-8.","journal-title":"J Neurol Sci"},{"key":"1549_CR28","doi-asserted-by":"publisher","first-page":"175628641983224","DOI":"10.1177\/1756286419832242","volume":"12","author":"C Schneider-Gold","year":"2019","unstructured":"Schneider-Gold C, Hagenacker T, Melzer N, Ruck T. Understanding the burden of refractory myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419832242. https:\/\/doi.org\/10.1177\/1756286419832242.","journal-title":"Ther Adv Neurol Disord"},{"key":"1549_CR29","doi-asserted-by":"publisher","first-page":"Doc12","DOI":"10.3205\/000239","volume":"14","author":"SR Sudulagunta","year":"2016","unstructured":"Sudulagunta SR, Sepehrar M, Sodalagunta MB, Settikere Nataraju A, Bangalore Raja SK, Sathyanarayana D, et al. Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab. Ger Med Sci. 2016;14:Doc12. https:\/\/doi.org\/10.3205\/000239.","journal-title":"Ger Med Sci"},{"key":"1549_CR30","first-page":"255","volume":"86","author":"J Suh","year":"2013","unstructured":"Suh J, Goldstein JM, Nowak RJ. Clinical characteristics of refractory myasthenia gravis patients. Yale J Biol Med. 2013;86:255\u201360.","journal-title":"Yale J Biol Med"},{"key":"1549_CR31","doi-asserted-by":"publisher","first-page":"E1782","DOI":"10.21037\/jtd.2016.12.80","volume":"8","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Sonnett JR, Aban IB, Kuo H-C, Cutter GR. Randomized trial of thymectomy in myasthenia gravis. J Thorac Dis. 2016;8:E1782\u20133. https:\/\/doi.org\/10.21037\/jtd.2016.12.80.","journal-title":"J Thorac Dis"},{"key":"1549_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM. MG-ADL: still a relevant outcome measure. Muscle Nerve. 2011;44:727\u201331. https:\/\/doi.org\/10.1002\/mus.22140.","journal-title":"Muscle Nerve"},{"key":"1549_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032487","volume":"7","author":"C Sardu","year":"2012","unstructured":"Sardu C, Cocco E, Mereu A, Massa R, Cuccu A, Marrosu MG, et al. Population Based Study of 12 Autoimmune Diseases in Sardinia, Italy: Prevalence and Comorbidity. PLoS One. 2012;7:e32487. https:\/\/doi.org\/10.1371\/journal.pone.0032487.","journal-title":"PLoS One"},{"key":"1549_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","volume":"48","author":"A Nacu","year":"2015","unstructured":"Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity. 2015;48:362\u20138. https:\/\/doi.org\/10.3109\/08916934.2015.1030614.","journal-title":"Autoimmunity."},{"key":"1549_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","volume":"120","author":"UK Misra","year":"2020","unstructured":"Misra UK, Kalita J, Singh VK, Kumar S. A study of comorbidities in myasthenia gravis. Acta Neurol Belg. 2020;120:59\u201364. https:\/\/doi.org\/10.1007\/s13760-019-01102-w.","journal-title":"Acta Neurol Belg"},{"key":"1549_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","volume":"91","author":"PB Christensen","year":"1995","unstructured":"Christensen PB, Jensen TS, Tsiropoulos I, S\u00f8rensen T, Kjaer M, H\u00f8jer-Pedersen E, et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand. 1995;91:192\u20135. https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb00432.x.","journal-title":"Acta Neurol Scand"},{"key":"1549_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.26695","volume":"60","author":"G Cutter","year":"2019","unstructured":"Cutter G, Xin H, Aban I, Burns TM, Allman PH, Farzaneh-Far R, et al. Cross-sectional analysis of the myasthenia gravis patient registry: disability and treatment. Muscle Nerve. 2019;60:707\u201315. https:\/\/doi.org\/10.1002\/mus.26695.","journal-title":"Muscle Nerve"},{"key":"1549_CR38","volume-title":"The quality of American life: perceptions, evaluations, and satisfactions","author":"A Campbell","year":"1976","unstructured":"Campbell A, Converse PE, Rodgers WL. The quality of American life: perceptions, evaluations, and satisfactions. New York: Russell Sage Foundation; 1976."},{"key":"1549_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10072-010-0285-6","volume":"31","author":"K Kulkantrakorn","year":"2010","unstructured":"Kulkantrakorn K, Sawanyawisuth K, Tiamkao S. Factors correlating quality of life in patients with myasthenia gravis. Neurol Sci. 2010;31:571\u20133. https:\/\/doi.org\/10.1007\/s10072-010-0285-6.","journal-title":"Neurol Sci"},{"key":"1549_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh MI, Dekker L, Maniaol AH, Brunborg C, Lipka AF, Niks EH, et al. An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts. Health Qual Life Outcomes. 2015;13:466. https:\/\/doi.org\/10.1186\/s12955-015-0298-1.","journal-title":"Health Qual Life Outcomes"},{"key":"1549_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10072-016-2556-3","volume":"37","author":"D Cioncoloni","year":"2016","unstructured":"Cioncoloni D, Casali S, Ginanneschi F, Carone M, Veronica B, Rossi A, Giannini F. Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients. Neurol Sci. 2016;37:717\u201323. https:\/\/doi.org\/10.1007\/s10072-016-2556-3.","journal-title":"Neurol Sci"},{"key":"1549_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000116785","volume":"32","author":"A Evoli","year":"2004","unstructured":"Evoli A, Batocchi AP, Palmisani MT, Lo Monaco M, Tonali P. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol. 2004;32:37\u201343. https:\/\/doi.org\/10.1159\/000116785.","journal-title":"Eur Neurol"},{"key":"1549_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.5692\/clinicalneurol.53.1299","volume":"53","author":"Y Nagane","year":"2013","unstructured":"Nagane Y. Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis. Rinsho Shinkeigaku. 2013;53:1299\u2013302. https:\/\/doi.org\/10.5692\/clinicalneurol.53.1299.","journal-title":"Rinsho Shinkeigaku"},{"key":"1549_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1525-1497.1997.07121.x","volume":"12","author":"S Woloshin","year":"1997","unstructured":"Woloshin S, Schwartz LM, Tosteson AN, Chang CH, Wright B, Plohman J, Fisher ES. Perceived adequacy of tangible social support and health outcomes in patients with coronary artery disease. J Gen Intern Med. 1997;12:613\u20138. https:\/\/doi.org\/10.1046\/j.1525-1497.1997.07121.x.","journal-title":"J Gen Intern Med"},{"key":"1549_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/art.1790070106","volume":"7","author":"KB Giorgino","year":"1994","unstructured":"Giorgino KB, Blalock SJ, DeVellis RF, DeVellis BM, Keefe FJ, Jordan JM. Appraisal of and coping with arthritis-related problems in household activities, leisure activities, and pain management. Arthritis Care Res. 1994;7:20\u20138. https:\/\/doi.org\/10.1002\/art.1790070106.","journal-title":"Arthritis Care Res"},{"key":"1549_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11205-010-9724-2","volume":"102","author":"A Braj\u0161a-\u017dganec","year":"2011","unstructured":"Braj\u0161a-\u017dganec A, Merka\u0161 M, \u0160verko I. Quality of life and leisure activities: how do leisure activities contribute to subjective well-being? Soc Indic Res. 2011;102:81\u201391. https:\/\/doi.org\/10.1007\/s11205-010-9724-2.","journal-title":"Soc Indic Res"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01549-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-020-01549-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01549-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T13:10:38Z","timestamp":1630674638000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-020-01549-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1186\/s12955-020-01549-z","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (The Ethics Committee of the Hong Kong Baptist University, reference number 12612018) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}